2225-1685

Eurasian heart journal

Intermedservice Ltd

View prefix report (10.38109)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 203 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact203 DOIs
2

Add abstracts to 47 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact47 DOIs
3

Deposit reference lists for 31 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact31 DOIs

DOIs for this ISSN

Showing the top 5 of 386 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 EURASIAN CLINICAL GUIDELINES ON DIAGNOSIS AND TREATMENT OF P… (10.38109/2225-1685-2020-1-78-122)
ORCID
46.73 73
2 EURASIAN CLINICAL GUIDELINES ON DIAGNOSIS AND TREATMENT OF A… (10.38109/2225-1685-2020-1-4-77)
ORCID
36.56 28
3 DIAGNOSTICS AND TREATMENT OF ARTERIAL HYPERTENSION (10.38109/2225-1685-2015-2-3-30)
ORCID
36.18 27
4 ACCORDING TO THE RESULTS OF THE EUROPEAN CONGRESS OF CARDIOL… (10.38109/2225-1685-2015-4-3-10)
References ORCID
34.95 4
5 EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT… (10.38109/2225-1685-2019-4-4-85)
ORCID
32.53 19
6 EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE… (10.38109/2225-1685-2021-2-6-61)
Abstract
30.76 16
7 VALUE OF VOLUME FRACTION OF COLLAGEN IN DEVELOPMENT OF MYOCA… (10.38109/2225-1685-2014-1-109-112)
Abstract ORCID
30.10 3
8 MECHANISMS OF PARASYMPATHETIC INFLUENCES ON THE HEART IN THE… (10.38109/2225-1685-2014-1-81-88)
Abstract ORCID
23.86 2
9 INNOVATION IN PHARMACEUTICAL TREATMENT OF PULMONARY ARTERIAL… (10.38109/2225-1685-2015-4-12-19)
Abstract ORCID
23.86 2
10 OPTIMAL CUT-OFF POINTS OF INSTANTANEOUS WAVE-FREE RATIO IN T… (10.38109/2225-1685-2016-4-34-41)
References ORCID
23.86 2
11 THE EFFECTIVENESS OF COMBINATION THERAPY WITH BOSENTAN AND S… (10.38109/2225-1685-2016-4-48-59)
Abstract References ORCID
22.58 1
12 PERFUSION LUNG SCINTIGRAPHY IN PATIENTS WITH A PULMONARY HYP… (10.38109/2225-1685-2015-4-20-25)
ORCID
17.47 4
13 OPTIMIZATION OF SPECIFIC THERAPY FOR PULMONARY ARTERIAL HYPE… (10.38109/2225-1685-2017-2-20-27)
ORCID
17.47 4
14 EVALUATION OF DEFORMATION OF THE LEFT VENTRICLE AND LEFT ATR… (10.38109/2225-1685-2018-2-4-15)
ORCID
17.47 4
15 THE ROLE OF ACTIVATION OF THE SYMPATHETIC NERVOUS SYSTEM IN… (10.38109/2225-1685-2018-3-88-94)
ORCID
17.47 4
16 INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH… (10.38109/2225-1685-2020-4-64-78)
Abstract
17.47 4
17 THE POSSIBILITY OF USING ELECTRONIC MEDICAL RECORDS FOR CLIN… (10.38109/2225-1685-2021-2-78-82)
Abstract
17.47 4
18 IDENTIFICATION OF THE ELECTROCARDIOGRAPHIC PREDICTORS OF THE… (10.38109/2225-1685-2011-1-21-27)
Abstract ORCID
15.05 1
19 THE PROBLEM OF THE QUALITY OF LIFE IN CHRONIC HEART FAILURE (10.38109/2225-1685-2012-1-49-56)
ORCID
15.05 3
20 DYAGNOSIS AND TREATMENT OF CARDIAC PULMONARY OEDEMA (10.38109/2225-1685-2012-2-6-15)
ORCID
15.05 3
21 EFFICACY OF IVABRADINE THERAPY ON RIGHT HEART PARAMETERS AND… (10.38109/2225-1685-2012-2-65-72)
Abstract ORCID
15.05 1
22 FEATURES OF ATHEROGENESIS AT SENSITIVITY INCREASE TO CANDIDA… (10.38109/2225-1685-2013-1-76-81)
Abstract ORCID
15.05 1
23 AMBRISENTAN: THE POSSIBILITY OF THE TREATMENT FOR PULMONARY… (10.38109/2225-1685-2014-1-95-108)
Abstract ORCID
15.05 1
24 CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRON… (10.38109/2225-1685-2014-2-4-37)
References ORCID
15.05 1
25 ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM., THE CLINIC… (10.38109/2225-1685-2014-2-63-70)
ORCID
15.05 3
26 FEATURES OF PULMONARY ARTERIAL HYPERTENSION IN THE RUSSIAN R… (10.38109/2225-1685-2014-4-44-53)
Abstract ORCID
15.05 1
27 INFLUENCE EVALUATION OF LONG-TERM THERAPY WITH EKVATOR® AND… (10.38109/2225-1685-2014-4-54-60)
ORCID
15.05 3
28 Out-patient monitoring of patients with coronary artery dise… (10.38109/2225-1685-2015-1-3-17)
References ORCID
15.05 1
29 THE PREDICTIVE VALUE OF THE INDEX BAEVSKY AND ITS RELATIONSH… (10.38109/2225-1685-2015-3-24-31)
Abstract ORCID
15.05 1
30 PULMONAR.Y ARTERIAL HYPERTENSION ASSOCIATED WITH A SYSTEMIC… (10.38109/2225-1685-2015-4-32-39)
ORCID
15.05 3
31 SURGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPER… (10.38109/2225-1685-2016-2-40-47)
ORCID
15.05 3
32 THE RESULTS OF LONG-TERM PAH-SPECIFIC MONOTHERAPY WITH BOSEN… (10.38109/2225-1685-2016-2-48-57)
Abstract ORCID
15.05 1
33 FEATURES OF CUTANEOUS MICROCIRCULATORY BLOOD FLOW IN PATIENT… (10.38109/2225-1685-2016-2-58-67)
ORCID
15.05 3
34 THE INFLUENCE OF CELL AND PLASMA HEMOSTASIS AND BIOMARKER LE… (10.38109/2225-1685-2016-4-26-33)
References ORCID
15.05 1
35 ATOMIC FORCE MICROSCOPY OF NEUTROPHILS IN PATIENTS WITH CHRO… (10.38109/2225-1685-2016-4-60-67)
References ORCID
15.05 1
36 HIGH ALTITUDE PULMONARY HYPERTENSION («MIRRAKHIMOV'S DISEASE… (10.38109/2225-1685-2016-4-76-83)
References ORCID
15.05 1
37 RUSSIAN GUIDELINES ON FAMILIAL HYPERCHOLESTEROLEMIA DIAGNOSI… (10.38109/2225-1685-2017-2-6-12)
References ORCID
15.05 1
38 A BRIEF SUMMARY OF THE RESULTS OF THE 6TH WORLD SYMPOSIUM ON… (10.38109/2225-1685-2018-2-84-91)
References ORCID
15.05 1
39 DIAGNOSIS AND TREATMENT OF MYOCARDITIDES. Draft clinical gui… (10.38109/2225-1685-2019-2-22-44)
References ORCID
15.05 1
40 DIAGNOSIS AND TREATMENT OF MYOCARDITIDES (10.38109/2225-1685-2019-3-4-33)
ORCID
15.05 3
41 COMBINATION THERAPY OF ARTERIAL HYPERTENSION - OUR EXPECTATI… (10.38109/2225-1685-2013-1-19-30)
ORCID
11.93 2
42 GLOMERULAR FILTRATION RATE AS A MARKER OF KIDNEY DAMAGE IN P… (10.38109/2225-1685-2014-2-44-48)
ORCID
11.93 2
43 APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS SILDENAFI… (10.38109/2225-1685-2015-2-42-49)
ORCID
11.93 2
44 CLINICAL AND HEMODYNAMIC PROFILE AND NEUROHORMONAL INDICATOR… (10.38109/2225-1685-2016-1-12-20)
ORCID
11.93 2
45 THE INFLUENCE OF OBSTRUCTIVE SLEEP APNEA AND PRIMARY SNORING… (10.38109/2225-1685-2016-1-34-38)
ORCID
11.93 2
46 ARTERIAL HYPERTENSION ASSOCIATED WITH METABOLIC SYNDROME: FO… (10.38109/2225-1685-2016-3-6-12)
ORCID
11.93 2
47 THE PROGNOSTIC IMPORTANCE OF RISK FACTORS AND MEDICAL HISTOR… (10.38109/2225-1685-2017-1-44-48)
ORCID
11.93 2
48 THE EFFECTIVENESS OF MEDICAL REHABILITATION IN CORONARY HEAR… (10.38109/2225-1685-2017-2-28-32)
ORCID
11.93 2
49 APPLICATION OF NEW ECHOCARDIOGRAPHIC TECHNOLOGIES OF NON-DOP… (10.38109/2225-1685-2017-2-42-47)
ORCID
11.93 2
50 IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENT… (10.38109/2225-1685-2017-4-100-109)
ORCID
11.93 2